Indian Government Expands Central Bank of India Stake Sale to 8 After OFS Attracts 236 Times Subscription Retail Bidding Opens Monday Tui Ends Sponsorship of Married at First Sight After Allegations of Sexual Misconduct on BBCs Panorama The AI Economy Reshapes Employment BlueCollar Workers Gain Ground as College Graduates Face Headwinds Analysts Eye ResMeds Sleep Tech Dominance What the Ratings Suggest Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers Oil Prices Rise as Trump Signals Tougher Iran Stance European Markets Slide Intelligent Bio Solutions Inc INBS Q1 2025 Earnings Wider Loss Than Expected Weighs on Shares BTSGU Q1 2026 Earnings EPS Surpasses Estimates by 23 Stock Flat amid Strong Operational Performance BKE Q1 2026 Earnings EPS Beats Estimates by 46 Amid Cautious Market Reaction TeraWulf Inc Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges OCS Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investments SWAG Q1 2026 Earnings Positive EPS Amid Limited Disclosure VNET Group Jumps 398 Approaching Key Resistance at 1042 Tortoise Energy Infrastructure TYG Slips 11 as Energy Sector Faces Headwinds Artelo Biosciences ARTL Gains 735 Biotech Stock Tests Resistance Near 153 IHS Holding IHS Gains 096 as Stock Approaches Key Technical Resistance PACS Group Inc PACS Slips Over 3 Support Levels in Focus After Recent Pullback Taboola Shares Slide as Market Weighs Growth Prospects Mannatech MTEX Surges Over 6 as Volume Picks Up Key Levels to Watch HubSpot HUBS Edges Higher as Investors Eye Key Resistance Level Fortive FTV Shows Modest Decline Amid Consolidation Range CDT Equity Inc Warrant CDTTW Holds at 001 Minimal Movement Amid Thin Trading Sound Point Meridian Capital Preferred SPME Holds Steady at 2509 A FixedIncome Anchor in Choppy Markets US Stock Futures and Bond Yields Slide on Reports of Putins Nuclear Doctrine Update Intercorp Financial Services Inc IFS Q1 2026 Earnings EPS Surprise Lifts Results Despite Tepid Stock Reaction Akebia Therapeutics AKBA Holds Steady at 102 as Stock Consolidates Near Key Support